ASC30
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity
Ascletis Pharma (China) Co · Phase 1 · Completed · Enrollment 72
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.